Clinical Trials Browser

Unknown × Glioblastoma × Therapeutics × Clear all

NCT04642937 2023-01-27

Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma

Phase 1 Unknown

Glioblastoma